Login

The views expressed in this program are those of the speakers and not necessarily those of Halo Securities LLC or its affiliates. 00:10:00

Share On Facebook Share On Twitter

David Parker · CEO at Halo Security

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Invests in early-stage technology companies working on ambitious solutions|David Helgason,Founder,Transition Global
00:10:00
Jennifer Terry on Jet Capital's Support, Culture, and Work Environment
00:10:00
Bannerman Energy: Advancing Namibia's Shovel-Ready Uranium Project
00:10:00
Strategies for Identifying Investment Opportunities Amid Market Volatility | Ali Dibadj , CEO , Janus Henderson.
00:10:00
Embrace of digital commerce has become a cornerstone of its economic landscape|Cindy Bi,General Partner, CapitalX
00:10:00
The Business of Fashion|Natalie Massenet,Co-Founder & Partner,Imaginary Ventures
00:10:00
Understanding the Santa Claus Rally and Its Impact on Stock Markets
00:10:00
Investing in next gen billion-dollar businesses that unapologetically benefit people|Elizabeth Galbut, Managing Partner,SoGal Ventures
00:10:00
Investing by targeting the Southeast and Midwest and placing|Paul Judge,Managing Partner,Panoramic Ventures
00:00:00
Dr. Elliot Goldstein, President and CEO of ProMIS Neurosciences
00:10:00
Unlocking the Future of Finance: Insights from Vincenza Larufa, Head of Financial Technology Group at Alkaline Capital Partners|Vincenzo La Ruffa,Managing Partner of Aquiline
00:10:00
Q2 2023 Market Update: Economic Insights | Lance Gunkel, Managing Director of Syverson Strege

© 2026 Nehu